We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-14.68%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$3.34B
AUM Growth
-$500M
(-13%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
9.82%
Holding
1,404
New
145
Increased
727
Reduced
365
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$16.4M |
| 2 |
Meta Platforms (Facebook)
META
|
+$13.4M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$7.87M |
| 4 |
EXE
Expand Energy Corp
EXE
|
+$7.36M |
| 5 |
Home Depot
HD
|
+$7.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$14M |
| 2 |
Procter & Gamble
PG
|
+$11.3M |
| 3 |
Kroger
KR
|
+$10.6M |
| 4 |
Northrop Grumman
NOC
|
+$8.11M |
| 5 |
Biogen
BIIB
|
+$8.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Energy | 13.98% |
| 3 | Healthcare | 13.42% |
| 4 | Industrials | 10.8% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Adaptive Biotechnologies
ADPT
$4.05B
| $92K | ﹤0.01% |
+11,700
| New | +$103K |
|
|
SGMO
1202
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $92K | ﹤0.01% |
22,210
+4,396
| +25% | +$19K |
|
|
DGXX
1203
Digi Power X Inc
DGXX
$370M
| $92K | ﹤0.01% |
89,753
+9,358
| +12% | +$19.4K |
|
1204
NeoGenomics
NEO
$2.14B
| $91K | ﹤0.01% |
+11,344
| New | +$108K |
|
|
EMBJ
1205
Embraer S.A. ADS
EMBJ
$13.1B
| $90K | ﹤0.01% |
10,376
-528
| -5% | -$5.65K |
|
|
DCFC
1206
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $90K | ﹤0.01% |
+74
| New | +$122K |
|
1207
Caribou Biosciences
CRBU
$165M
| $89K | ﹤0.01% |
16,479
-55,887
| -77% | -$427K |
|
1208
Nomura Holdings
NMR
$28.7B
| $87K | ﹤0.01% |
+25,847
| New | +$98.7K |
|
1209
Turkcell
TKC
$4.79B
| $87K | ﹤0.01% |
+35,832
| New | +$116K |
|
1210
Recursion Pharmaceuticals
RXRX
$1.76B
| $85K | ﹤0.01% |
+10,481
| New | +$70.1K |
|
|
ZSTK
1211
ZeroStack Corp
ZSTK
$17.3M
| $84K | ﹤0.01% |
177
+9
| +5% | +$8.53K |
|
|
NVTA
1212
DELISTED
Invitae Corporation
NVTA
| $84K | ﹤0.01% |
+34,913
| New | +$154K |
|
1213
BlackSky Technology
BKSY
$1.17B
| $81K | ﹤0.01% |
4,400
-1,740
| -28% | -$26.5K |
|
1214
Bioventus
BVS
$1.17B
| $78K | ﹤0.01% |
11,500
+567
| +5% | +$5.79K |
|
1215
The RealReal
REAL
$1.45B
| $78K | ﹤0.01% |
+31,308
| New | +$139K |
|
1216
Satellogic
SATL
$819M
| $76K | ﹤0.01% |
+18,694
| New | +$120K |
|
|
AVX
1217
Avax One Technology Ltd
AVX
$26.1M
| – | – |
0
| – | – |
|
|
KLR
1218
DELISTED
Kaleyra, Inc.
KLR
| $74K | ﹤0.01% |
10,304
+1,036
| +11% | +$15.2K |
|
1219
Spire Global
SPIR
$543M
| $71K | ﹤0.01% |
7,640
-869
| -10% | -$11.1K |
|
|
VLTA
1220
DELISTED
Volta Inc.
VLTA
| $70K | ﹤0.01% |
53,996
+6,173
| +13% | +$13.8K |
|
|
NBEV
1221
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $69K | ﹤0.01% |
314,149
+15,083
| +5% | +$5.7K |
|
1222
Evogene
EVGN
$7.65M
| $68K | ﹤0.01% |
8,771
+384
| +5% | +$3.75K |
|
|
VIP
1223
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$29.9M
| $68K | ﹤0.01% |
2,679
-363
| -12% | -$20.4K |
|
1224
Corbus Pharmaceuticals
CRBP
$177M
| $67K | ﹤0.01% |
8,920
+415
| +5% | +$4.01K |
|
1225
Enel Chile
ENIC
$6.2B
| $65K | ﹤0.01% |
62,485
+35,487
| +131% | +$48.9K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2022 Portfolio in Review
As of Q2 2022, Vident Investment Advisory held 1,404 positions worth $3.34B, down 13% from $3.84B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Vident Investment Advisory deployed $164M of net new capital in Q2 2022, opening 145 new positions and adding to 727 existing holdings. Its largest new stake was Samsara: 1,361,007 shares worth $15.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Walmart Inc, an estimated $14M trimmed.
- Vident Investment Advisory's largest Q2 2022 buy was Samsara: 1,361,007 shares worth $15.2M.
- Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2022, an estimated $13.4M increase.
- Vident Investment Advisory's biggest Q2 2022 reduction was Walmart Inc, cutting an estimated $14M.
- Vident Investment Advisory fully exited Cerner Corp in Q2 2022, selling an estimated $7.01M.
- Vident Investment Advisory's ten largest holdings make up 9.8% of its $3.34B portfolio in Q2 2022.
- Vident Investment Advisory opened 145 new positions and closed 141 in Q2 2022.
- Vident Investment Advisory's portfolio value fell 13% quarter-over-quarter to $3.34B.
Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.